Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer remains the most lethal gynecological cancer in women. There is a critical need to develop novel strategies that can be used to improve the survival of patients with advanced and recurrent ovarian cancer. Preclinical and early clinical studies with single-targeted agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Lu, Leander X., Wu, Jun, Jove, Richard, Yim, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564386/
https://www.ncbi.nlm.nih.gov/pubmed/32927828
http://dx.doi.org/10.3390/cancers12092586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564386/
https://www.ncbi.nlm.nih.gov/pubmed/32927828
http://dx.doi.org/10.3390/cancers12092586

Ejemplares similares